XML 43 R37.htm IDEA: XBRL DOCUMENT v3.25.2
Revenue Recognition - Schedule of net revenue from collaboration arrangement (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue Recognition and Collaboration Arrangements        
Total net royalty revenue $ 100,283 $ 99,898 $ 188,915 $ 177,397
Royalty Revenue        
Revenue Recognition and Collaboration Arrangements        
Total net royalty revenue 63,880 63,742 121,687 122,157
GSK | Royalty Revenue        
Revenue Recognition and Collaboration Arrangements        
Total royalties 67,336 67,198 128,599 129,069
Less: amortization of capitalized fees paid (3,456) (3,456) (6,912) (6,912)
Total net royalty revenue 63,880 63,742 121,687 122,157
GSK | ANORO        
Revenue Recognition and Collaboration Arrangements        
Total royalties 12,599 13,218 22,972 22,951
GSK | RELVAR/BREO        
Revenue Recognition and Collaboration Arrangements        
Total royalties $ 54,737 $ 53,980 $ 105,627 $ 106,118